D06.9 Code facturable et spécifique Carcinoma in situ of cervix, unspecified
ICD-10-CM D06.9 identifies “Carcinoma in situ of cervix, unspecified” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapitre 2: Neoplasms
Instructions du code
Aucune note supplémentaire.
Instructions des niveaux supérieurs
Chapitres 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
D00-D09 · In situ neoplasms (D00-D09)
Includes4
- Bowen's disease
- erythroplasia
- grade III intraepithelial neoplasia
- Queyrat's erythroplasia
D06 · Carcinoma in situ of cervix uteri
Includes4
- cervical adenocarcinoma in situ
- cervical intraepithelial glandular neoplasia
- cervical intraepithelial neoplasia III [CIN III]
- severe dysplasia of cervix uteri
Références de l’index officiel
Références de l’index officiel (12)
Adenocarcinoma (1)
- Adenocarcinoma › cervix, in situIndex des maladies
Carcinoma-in-situ (4)
- Carcinoma-in-situ › epidermoid › with questionable stromal invasion › cervixIndex des maladies
- Carcinoma-in-situ › epidermoid › with questionable stromal invasion › unspecified siteIndex des maladies
- Carcinoma-in-situ › squamous cell › with questionable stromal invasion › cervixIndex des maladies
- Carcinoma-in-situ › squamous cell › with questionable stromal invasion › unspecified siteIndex des maladies
Carcinoma(malignant) (1)
- Carcinoma(malignant) › cervix uteri › in situIndex des maladies
Dysplasia (1)
- Dysplasia › cervix(uteri) › severeIndex des maladies
Neoplasia (3)
- Neoplasia › intraepithelial(histologically confirmed) › cervical glandular(histologically confirmed)Index des maladies
- Neoplasia › intraepithelial(histologically confirmed) › cervix(uteri) (CIN) (histologically confirmed) › glandularIndex des maladies
- Neoplasia › intraepithelial(histologically confirmed) › cervix(uteri) (CIN) (histologically confirmed) › grade III(severe dysplasia)Index des maladies
Neoplasm, neoplastic (2)
Historique
Historique du code
Aucune modification depuis la première observation
ModifiéInchangé
FY2016
En vigueur dès le
- Première observation
Carcinoma in situ of cervix, unspecified
Code de diagnostic facturable
CDC/NCHS · FY2016Toutes les éditions (19)
| Toutes les éditions | En vigueur dès le | Historique du code |
|---|---|---|
| FY2016 | 2015-10-01 | Première observation |
| FY2017 | 2016-10-01 | Aucun changement tabulaire |
| FY2018 | 2017-10-01 | Aucun changement tabulaire |
| FY2019 | 2018-10-01 | Aucun changement tabulaire |
| FY2020 | 2019-10-01 | Aucun changement tabulaire |
| FY2020 · April | 2020-04-01 | Aucun changement tabulaire |
| FY2021 | 2020-10-01 | Aucun changement tabulaire |
| FY2021 · 01-01 | 2021-01-01 | Aucun changement tabulaire |
| FY2022 | 2021-10-01 | Aucun changement tabulaire |
| FY2022 · 04-01 | 2022-04-01 | Aucun changement tabulaire |
| FY2023 | 2022-10-01 | Aucun changement tabulaire |
| FY2023 · 04-01 | 2023-04-01 | Aucun changement tabulaire |
| FY2024 | 2023-10-01 | Aucun changement tabulaire |
| FY2024 · 04-01 | 2024-04-01 | Aucun changement tabulaire |
| FY2025 | 2024-10-01 | Aucun changement tabulaire |
| FY2025 · 04-01 | 2025-04-01 | Aucun changement tabulaire |
| FY2026 | 2025-10-01 | Aucun changement tabulaire |
| FY2026 · April | 2026-04-01 | Aucun changement tabulaire |
| FY2027 | 2026-10-01 | Aucun changement tabulaire |
Correspondances ICD-9 historiques · 2018
Correspondance historique uniquement ; pas de substitution automatique.
- 233.1 · Approximative
Cette entrée est un code complet dans l’édition sélectionnée. La vérification du référentiel ne confirme pas la pertinence clinique et ne garantit pas le remboursement.